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a Score was 0 if patient had р1 opportunistic infection; 1 if patient had 11 opportunistic infection, a baseline CD8 + T cell count 1468.5 cells/mL, and a baseline hemoglobin level 110.2 g/dL; 2 if a patient had 11 opportunistic infection, a baseline CD8 + T cell count 1468.5 cells/mL, and a baseline hemoglobin level р10.2 g/dL; 3 if patient had 11 opportunistic infection, a baseline CD8 + T cell count of р468.5 cells/mL, and a baseline hemoglobin level 113.6 g/dL; and 4 if a patient had 11 opportunistic infection, a baseline CD8 + T cell count of 1468.5 cells/mL, and a baseline hemoglobin level р13.6 g/dL. b Evidence of IRS is not available, because patient case note was not available or was incomplete.
Predicting Immune Reconstitution Syndrome
To the Editor-Immune reconstitution syndrome (IRS) is a potential complication following the initiation of HAART in HIV-infected patients [1] [2] [3] [4] . There is currently no consensus on the diagnostic criteria for IRS, but a number of criteria have been proposed [2, 5] . In a retrospective case-control study, Robertson et al. [6] developed a statistical model to predict IRS cases that was based on the number of prior opportunistic infections (OI) and on the patient's CD8 + T cell count and hemoglobin level prior to initiation of HAART.
We evaluated this model using data from the TREAT Asia HIV Observational Database (TAHOD), a multicenter, prospective cohort of HIV-infected patients involving 15 sites in the Asia-Pacific region [7] . Studies show that the majority of cases of IRS occur within the first 2-3 months after starting treatment [1, 3, 4] . We identified 75 patients who had an AIDS-defining illness (ADI) that was diagnosed within 90 days after treatment initiation. We retrospectively assessed these ADIs for evidence of IRS using a modification of the IRS diagnosis criteria proposed by French et al.
[2], and we specified a CD4 + T cell count increase of at least 50 cells/mL after initiation of HAART [8] . Clinicians at the respective sites retrospectively classified each new ADI as (1) definitive IRS if the case met all the proposed requirements, (2) presumptive IRS if there was some evidence but not all of the requirements were met, (3) not IRS if there was no evidence of diagnostic criteria, or (4) unknown because of unavailability or incompleteness of the patient's case history. After checking the patient case histories, it was determined that 2 (3%) of the patients had definite IRS, 19 (25%) had presumptive IRS, 44 (59%) did not have IRS, and 10 (13%) had unavailable or incomplete documents.
To assess the predictive model developed by Robertson et al. [6] , we applied that model to data from TAHOD. Of the 75 patients who developed an ADI within 90 days after initiation of HAART, 65 were evaluated for IRS according to our criteria; of these, 53 had the required baseline CD8 + T cell count and hemoglobin level (table 1) . Of these 53 patients, 14 (26%) were classified as having definite or presumptive IRS, and 39 (76%) were classified as not having IRS. The predictive model correctly identified 2 of the 14 cases of IRS using either a score of у2 or у4 and a sensitivity of 14%. The model correctly identified 32 and 36 of the non-IRS cases using scores of у2 and у4, respectively, and specificities of 79% and 92%, respectively.
There are differences between our study methodology and that used by Robertson et al. [6] . We only examined cases of IRS among patients with ADIs, and we also used different-albeit similar-IRS diagnostic criteria, without blinded review. However, the model developed by Robertson et al. [6] did not accurately predict cases of new ADIs due to IRS among the Asian HIV-infected patients in TAHOD on the basis of routinely available clinical data. This may be related to the different epidemiology of HIV illnesses in Asian populations and, in particular, the greater rates of TB among these populations [7, 9]. 
Reply to Zhou and Ditangco
To the Editor--In their letter, Zhou and Ditangco [1] report the results of their evaluation of our classification and regression tree model [2] for prediction of immune reconstitution syndrome (IRS) using data from the Therapeutics Research Education AIDS Training (TREAT) Asia HIV Observational Database (TAHOD) [3] . They report that, with a sensitivity of 14%, our model did not accurately predict cases of IRS. There are a number of possible explanations for why our model did not accurately predict cases of IRS in this population.
Our model may be limited, because we identified cases of IRS retrospectively and matched them to control subjects by CD4 + T cell count. Consequently, all subjects had low CD4 + T cell counts (!50 cells/ mm 3 ), and thus, the statistical models we developed may only be valid in this population. This may account for some of the inaccuracy in our model's ability to predict cases of IRS in the TAHOD patients. Of the 53 subjects with baseline data in the TAHOD study, 44 had baseline CD4 + T cell counts. Of these, 50% had CD4 + T cell counts !50 cells/mm 3 . Fourteen cases of IRS were identified (illnesses not specified), but it is not clear how many had low CD4 + T cell counts. Six of the 22 subjects with low CD4 + T cell counts had IRS scores of у2. The model predicted 2 of the 14 cases, but 12 cases were assigned scores of 0. Thus, the CD4 + T cell count limitation does not entirely explain the inaccuracy that was observed.
Although similar criteria for identifying cases of IRS were used by Zhou et al. 3, it is possible that not all AIDS defining illnesses (ADIs) that were identified were cases of IRS. The ADIs that were identified are summarized in table 1. Although a variety of opportunistic infections have been reported to occur as immune reconstitution phenomena, not all have been confirmed to occur as a part of IRS.
For example, esophageal candidiasis, HIV wasting syndrome, and pneumonia have not been reported as illnesses associated with IRS. The lack of a gold standard test for confirming IRS is a confounding factor for both the construction and testing of predictive models. Thus, Zhou and Ditangco may have been comparing early ADIs rather than true cases of IRS.
Another possible explanation is the differences in epidemiology of ADIs in Asian populations-in particular, high rates of tuberculosis. Nearly one-half (43.4%) of the events that were observed in the 53 study subjects were related to tuberculosis. Immune reconstitution events related to the treatment of tuberculosis have long been known to occur independently of HIV infection. IRS has previously been reported to occur in as many as 40% of patients coinfected with HIV and tuberculosis who start antiretroviral therapy [4] . In addition, high rates of tuberculosis have been reported within 3 months after initiating antiretroviral therapy in HIV patients who live in countries where tuberculosis is prevalent [5] . It is likely that tuberculosis represents a significant independent risk factor for the development of IRS. We agree with Zhou and Ditangco [1] that a high prevalence of tuberculosis may have contributed significantly to the inaccuracy of our predictive model in the
